Egfr
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
Coverage of Egfr is accelerating : 6 signals on the latest tracked day, up 50% from its three-week baseline of 4, across 6 domains (unchanged from a week ago).
If Egfr matters to your work, the information environment around it is moving faster than its own baseline — worth a daily look while the build lasts.
What’s changed
7 of the last 7 tracked days ran above the three-week baseline — a sustained move, not a one-day spike.
- Optimal duration of preventive minocycline for anti-EGFR skin side effects studied · crc-digest · 2026-09-17
- Case Report: Dramatic response of trastuzumab rezetecan in an NSCLC patient with EGFR sensitive mutation and primary ERBB2 genetic alterations · Frontiers Precision Oncology · 2026-09-16
- From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies. · Immunotherapy · 2026-09-15
- GSK to license Hutchmed’s KRAS-EGFR cancer drug for $110M upfront · Endpoints News · 2026-09-03
- The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity. · Cancer Res · 2026-09-01
- SystImmune, Inc. to Present New Global Data on Iza-bren (izalontamab brengitecan) in EGFR-mutated Non-Small Cell Lung Cancer at WCLC Congress 2026 · PR Newswire — All News Releases · 2026-09-12 · usually covers Deal Primary
What the reporting says
It shows up alongside Colorectal Cancer (63), Lung Cancer (39), KRAS (37), Braf (31), Immunotherapy (29), Overall Survival (29), Her2 (24), ctDNA (17).
Two steps out: AI (through Colorectal Cancer, 63 shared stories on the weaker link); MSI-H (through Colorectal Cancer, 63 shared stories on the weaker link); Wang (through Colorectal Cancer, 63 shared stories on the weaker link); Zhang (through Colorectal Cancer, 58 shared stories on the weaker link).
Tracked since Mar 12, with coverage on 71 separate days — concentrated in Oncology and Pubmed Targeted.